Provided by Tiger Fintech (Singapore) Pte. Ltd.

Chimerix

8.46
+0.03000.36%
Post-market: 8.44-0.0200-0.24%16:19 EDT
Volume:4.30M
Turnover:36.24M
Market Cap:760.86M
PE:-9.01
High:8.46
Open:8.42
Low:8.42
Close:8.43
Loading ...

CrowdStrike reports Q4 beat, Jazz to acquire Chimerix: Morning Buzz

TIPRANKS
·
06 Mar

Chimerix Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
06 Mar

Chimerix a Prime Acquisition Candidate for Jazz Pharmaceuticals Due to Dordaviprone, Wedbush Says

MT Newswires Live
·
05 Mar

Hold Rating Issued Amidst Chimerix Acquisition by Jazz Pharmaceuticals

TIPRANKS
·
05 Mar

Strategic Acquisition: Jazz Pharmaceuticals’ Buy Rating Boosted by Chimerix Deal and Dordaviprone’s Market Potential

TIPRANKS
·
05 Mar

Chimerix downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
05 Mar

Chimerix Shares Take Flight on Takeover by Jazz Pharmaceuticals

Dow Jones
·
05 Mar

Chimerix, Inc. : H.c. Wainwright Cuts Target Price to $8.55 From $11

THOMSON REUTERS
·
05 Mar

Chimerix Shares Jump 69.4% to More Than Three Year High After Jazz Pharmaceuticals to Buy Co for $935 Million

THOMSON REUTERS
·
05 Mar

BUZZ-U.S. STOCKS ON THE MOVE-AppLovin, crypto stocks, KKR

Reuters
·
05 Mar

Wedbush Downgrades Chimerix to Neutral From Outperform, Adjusts Price Target to $8.55 From $7

MT Newswires Live
·
05 Mar

Jazz's Chimerix Deal Could Bring Valuable FDA Voucher -- Market Talk

Dow Jones
·
05 Mar

Investors Look for Signs of Tariff Easing as US Futures Rise Modestly Pre-Bell

MT Newswires Live
·
05 Mar

Chimerix Inc : Wedbush Cuts to Neutral From Outperform; Raises Target Price to $8.55 From $7

THOMSON REUTERS
·
05 Mar

BRIEF-Jazz Pharmaceuticals Upon Termination Of Deal Chimerix Will Be Required To Pay Termination Fee Of $35 Million In Cash

Reuters
·
05 Mar

BRIEF-Jazz Pharmaceuticals To Acquire Chimerix

Reuters
·
05 Mar